Abstract:Background A major obstacle to the development of personalized therapies for gastric cancer (GC) is the prevalent heterogeneity at the intra-tumor, intra-patient, and inter-patient levels. Although the pathological stage and histological subtype diagnosis can approximately predict prognosis, GC heterogeneity is rarely considered. The extracellular matrix (ECM), a major component of the tumor microenvironment (TME), extensively interacts with tumor and immune cells, providing a possible proxy to investigate GC heterogeneity. However, ECM consists of numerous protein components, and there are no suitable models to screen ECM-related genes contributing to tumor growth and prognosis. We constructed patient-derived tumor xenograft (PDTX) models to obtain robust ECM-related transcriptomic signatures to improve GC prognosis prediction and therapy design. Methods One hundred twenty two primary GC tumor tissues were collected to construct PDTX models. The tumorigenesis rate and its relationship with GC prognosis were investigated. Transcriptome profiling was performed for PDTX-originating tumors, and least absolute shrinkage and selection operator (LASSO) Cox regression analysis was applied to extract prognostic ECM signatures and establish PDTX tumorigenicity-related gene (PTG) scores. The predictive ability of the PTG score was validated using two independent cohorts. Finally, we combined PTG score, age, and pathological stage information to establish a robust nomogram for GC prognosis prediction. Results We found that PDTX tumorigenicity indicated a poor prognosis in patients with GC, even at the same pathological stage. Transcriptome profiling of PDTX-originating GC tissues and corresponding normal controls identified 383 differentially expressed genes, with enrichment of ECM-related genes. A robust prognosis prediction model using the PTG score showed robust performance in two validation cohorts. A high PTG score was associated with elevated M2 polarized macrophage and cancer-associated fibroblast infiltration. Finally, combining the PTG score with age and TNM stage resulted in a more effective prognostic model than age or TNM stage alone. Conclusions We found that ECM-related signatures may contribute to PDTX tumorigenesis and indicate a poor prognosis in GC. A feasible survival prediction model was built based on the PTG score, which was associated with immune cell infiltration. Together with patient ages and pathological TNM stages, PTG score could be a new approach for GC prognosis prediction.

Zinc Finger Protein CTCF Regulates Extracellular Matrix (ECM)-Related Gene Expression Associated With the Wnt Signaling Pathway in Gastric Cancer

Zic1 Suppresses Gastric Cancer Metastasis by Regulating Wnt/β‐catenin Signaling and Epithelial‐mesenchymal Transition

LZTFL1 Suppresses Gastric Cancer Cell Migration and Invasion Through Regulating Nuclear Translocation of Β-Catenin.

Differential Expression of COL6 Family is a Potential Tumor Marker for Predicting Gastric Cancer

ZNF418 Overexpression Protects Against Gastric Carcinoma and Prompts a Good Prognosis

The Keratin 17/YAP/IL6 Axis Contributes to E-cadherin Loss and Aggressiveness of Diffuse Gastric Cancer

CXXC4 activates apoptosis through up-regulating GDF15 in gastric cancer.

Extracellular Matrix Characterization in Gastric Cancer Helps to Predict Prognosis and Chemotherapy Response

Zinc Finger Proteins in the War on Gastric Cancer: Molecular Mechanism and Clinical Potential

Progressive and Prognostic Performance of an Extracellular Matrix-Receptor Interaction Signature in Gastric Cancer

ZEB1-induced LINC01559 expedites cell proliferation, migration and EMT process in gastric cancer through recruiting IGF2BP2 to stabilize ZEB1 expression

High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer

ZC3H15 promotes gastric cancer progression by targeting the FBXW7/c-Myc pathway

Extracellular Matrix-Based Gene Signature for Predicting Prognosis in Colon Cancer and Immune Microenvironment.

Potential regulation and prognostic model of colorectal cancer with extracellular matrix genes

Transcriptome Profiling of Patient-Derived Tumor Xenografts Suggests Novel Extracellular Matrix-Related Signatures for Gastric Cancer Prognosis Prediction

USP51/ZEB1/ACTA2 axis promotes mesenchymal phenotype in gastric cancer and is associated with low cohesion characteristics

Decreased Expression of ATF3, Orchestrated by Β-Catenin/tcf3, Mir-17-5p and HOXA11-AS, Promoted Gastric Cancer Progression Via Increased Β-Catenin and CEMIP

Integrative Analysis of Cancer-Associated Fibroblast Signature in Gastric Cancer

Proteomic Heterogeneity of the Extracellular Matrix Identifies Histologic Subtype-Specific Fibroblast in Gastric Cancer

Comprehensive Analysis Reveals CTHRC1, SERPINE1, VCAN and UPK1B As the Novel Prognostic Markers in Gastric Cancer.